Hassan Fred - Sep 3, 2024 Form 4 Insider Report for EyePoint Pharmaceuticals, Inc. (EYPT)

Role
Director
Signature
/s/ Ron Honig, Attorney-in-Fact
Stock symbol
EYPT
Transactions as of
Sep 3, 2024
Transactions value $
$0
Form type
4
Date filed
9/5/2024, 04:02 PM
Previous filing
Jun 25, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EYPT Stock Options (Right to buy) Award $0 +60K $0.00 60K Sep 3, 2024 Common Stock 60K $8.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option becomes exercisable in three ratable annual installments beginning on September 3, 2025.